2016 Digestive Disease Week

Caroline Helwick / June 25, 2016 / 2016 Digestive Disease Week

Expert Point of View: Samir Gupta, MD

Samir Gupta, MD, Associate Professor of Medicine at the University of California San Diego, who has led trials of colorectal cancer screening, commented on this study for The ASCO Post. Although the...

Colorectal Cancer

Caroline Helwick / June 25, 2016 / 2016 Digestive Disease Week

Young-Onset Colorectal Cancer Diagnoses Rising

Colorectal cancer is being increasingly diagnosed in persons younger than age 50, the age at which colorectal cancer screening is usually initiated. According to Elie Sutton, MD, of Mount Sinai West...

Oct

Today In Oncology

IASLC 2017: Exercise Interventions in Advanced Lung Cancer Patients Led to Increased Functionality

IASLC 2017: Community Engagement Interventions May Reduce Disparities in Lung Cancer Outcomes Among Minorities

IASLC 2017: Non–Small Cell Lung Cancer Survival Rates Higher Among Patients Treated at Academic Centers

IASLC 2017: Poziotinib Yields High Response Rates in Patients With NSCLC With EGFR Exon 20 Insertion

2016 Digestive Disease Week

Expert Point of View: Samir Gupta, MD

Young-Onset Colorectal Cancer Diagnoses Rising

IASLC 2017: Exercise Interventions in Advanced Lung Cancer Patients Led to Increased Functionality

IASLC 2017: Community Engagement Interventions May Reduce Disparities in Lung Cancer Outcomes Among Minorities

IASLC 2017: Non–Small Cell Lung Cancer Survival Rates Higher Among Patients Treated at Academic Centers

IASLC 2017: Poziotinib Yields High Response Rates in Patients With NSCLC With EGFR Exon 20 Insertion

Survival in Patients Treated With Adjuvant Chemoradiotherapy After Resection of Gastric Cancer

Sperm Banking for Adolescent Males With Newly Diagnosed Cancer

IASLC 2017: First-Line Pembrolizumab Increases Overall Survival vs Chemotherapy in Metastatic NSCLC With High Levels of PD-L1

FDA Approves CAR T-Cell Therapy to Treat Adults With Certain Types of Large B-Cell Lymphoma

Immunotherapy for Previously Treated Advanced Gastric Cancer

FDA Approves CAR T-Cell Therapy to Treat Adults With Certain Types of Large B-Cell Lymphoma

Combination Therapy for Patients With Advanced Unresectable Melanoma

Outcomes in Patients With Metastatic Lung Cancer Receiving PD-1/PD-L1 Inhibitors With Thoracic Radiotherapy

Survival in Patients Treated With Adjuvant Chemoradiotherapy After Resection of Gastric Cancer

IASLC 2017: CheckMate-032: Nivolumab Alone or With Ipilimumab in Recurrent SCLC With High Tumor Mutation Burden

IASLC 2017: Lorlatinib in ALK-Positive and ROS1-Positive Advanced Non–Small Cell Lung Cancer

Addition of EGFR Tyrosine Kinase Inhibitor to Chemotherapy in Resistant Non–Small Cell Lung Cancer

A Gleason 6 Tumor: Is It Cancer, and Should It Be Treated?

PI3K Inhibition in Relapsed or Refractory Indolent Lymphoma